Despite their importance, working with drug intermediates presents various challenges. One significant issue is the scalability of the synthesis process. While a laboratory may successfully produce a drug intermediate in small quantities, reproducing that process on a larger scale for commercial production can be complicated. Factors such as reaction conditions, temperature, humidity, and raw material availability can all affect the yield and quality of intermediates during scale-up.